Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography

Department of Radiological Sciences, University of California-Los Angeles.

To determine if imaging of blood flow (using N-13 ammonia) and glucose metabolism (using F-18 2-deoxyglucose) with positron emission tomography can distinguish cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy, 21 patients with severe left ventricular dysfunction who were evaluated for cardiac transplantation were studied. The origin of left ventricular dysfunction had been previously determined by coronary angiography to be ischemic (11 patients) or nonischemic (10 patients). Images were visually analyzed by three observers on a graded scale in seven left ventricular segments and revealed fewer defects in dilated cardiomyopathy compared with ischemic cardiomyopathy for N-13 ammonia (2.7 +/- 1.6 versus 5 +/- 0.6; p less than 0.03) and F-18 deoxyglucose (2.8 +/- 2.1 versus 4.6 +/- 1.1; p less than 0.03). An index incorporating extent and severity of defects revealed more homogeneity with fewer and less severe defects in subjects with nonischemic than in those with ischemic cardiomyopathy as assessed by imaging of flow (2.8 +/- 1.8 versus 9.2 +/- 3; p less than 0.001) and metabolism (3.8 +/- 3.3 versus 8.5 +/- 3.6; p less than 0.005). Diagnostic accuracy for distinguishing the two subgroups by visual image analysis was 85%. Using previously published circumferential count profile criteria, patients with dilated cardiomyopathy had fewer ischemic segments (0.4 +/- 0.8 versus 2.5 +/- 2 per patient; p less than 0.01) and infarcted segments (0.1 +/- 0.3 versus 2.4 +/- 1.4 per patient; p less than 0.001) than did patients with cardiomyopathy of coronary artery disease. The sensitivity for differentiating the two clinical subgroups using circumferential profile analysis was 100% and the specificity 80%. An index incorporating both number and severity of defects derived from circumferential profile analysis was significantly lower in subjects with dilated cardiomyopathy than in ischemic cardiomyopathy (0.3 +/- 0.8 versus 2.7 +/- 2.4; p less than 0.005). Thus, noninvasive positron emission tomographic imaging with N-13 ammonia and F-18 deoxyglucose is helpful in distinguishing patients with severe left ventricular dysfunction secondary to coronary artery disease from those with nonischemic cardiomyopathy, and a semiquantitative index such as circumferential profile analysis is superior to that of visual analysis alone.

This article has been cited by other articles:

				K. Nasir, M. Tsai, B. D. Rosen, V. Fernandes, D. A. Bluemke, A. R. Folsom, and J. A.C. Lima Elevated Homocysteine Is Associated With Reduced Regional Left Ventricular Function: The Multi-Ethnic Study of Atherosclerosis Circulation, January 16, 2007; 115(2): 180 - 187. [Abstract] [Full Text] [PDF]

				G. M. Felker, L. K. Shaw, and C. M. O'Connor A standardized definition of ischemic cardiomyopathy for use in clinical research J. Am. Coll. Cardiol., January 16, 2002; 39(2): 210 - 218. [Abstract] [Full Text] [PDF]

				A.E Androulakis, G.K Andrikopoulos, D.J Richter, C.A Tentolouris, C.C Avgeropoulou, D.A Adamopoulos, P.K Toutouzas, A.G Trikas, C.I Stefanadis, and J.E Gialafos The role of carotid atherosclerosis in the distinction between ischaemic and non-ischaemic cardiomyopathy Eur. Heart J., June 1, 2000; 21(11): 919 - 926. [Abstract] [PDF]

				M. A. Auerbach, H. Schoder, C. Hoh, S. S. Gambhir, S. Yaghoubi, J. W. Sayre, D. Silverman, M. E. Phelps, H. R. Schelbert, and J. Czernin Prevalence of Myocardial Viability as Detected by Positron Emission Tomography in Patients With Ischemic Cardiomyopathy Circulation, June 8, 1999; 99(22): 2921 - 2926. [Abstract] [Full Text] [PDF]

				F. Follath, J. G. F. Cleland, W. Klein, and R. Murphy Etiology and response to drug treatment in heart failure J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1167 - 1172. [Abstract] [Full Text] [PDF]

				M. J. Budoff, D. M. Shavelle, D. H. Lamont, H. T. Kim, P. Akinwale, J. M. Kennedy, and B. H. Brundage Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1173 - 1178. [Abstract] [Full Text] [PDF]

				M.G. Niemeyer, A.F.M. Kuijper, J.G. Meeder, M.J.M. Cramer, A.J.M. Cleophas, E.E. van der Wall, and M. G. Niemeyer Comparison of Thallium Scintigraphy and Positron Emission Tomography Angiology, October 1, 1997; 48(10): 843 - 853. [Abstract] [PDF]

				A. Cohen, C. Chauvel, B. Benhalima, P. Guyon, I. Desert, J. Valty, and A. Cohen Is Dobutamine Stress Echocardiography Useful for Noninvasive Differentiation of Ischemic from Idiopathic Dilated Cardiomyopathy? Angiology, September 1, 1997; 48(9): 783 - 793. [Abstract] [PDF]

				D. F. Vitale, R. O. Bonow, G. Gerundo, N. Pelaggi, G. Lauria, D. Leosco, F. Coltorti, C. Bordini, C. Rengo, and F. Rengo Alterations in Ultrasonic Backscatter During Exercise-Induced Myocardial Ischemia in Humans Circulation, September 15, 1995; 92(6): 1452 - 1457. [Abstract] [Full Text]

				D. Neglia, O. Parodi, M. Gallopin, G. Sambuceti, A. Giorgetti, L. Pratali, P. Salvadori, C. Michelassi, M. Lunardi, G. Pelosi, et al. Myocardial Blood Flow Response to Pacing Tachycardia and to Dipyridamole Infusion in Patients With Dilated Cardiomyopathy Without Overt Heart Failure : A Quantitative Assessment by Positron Emission Tomography Circulation, August 15, 1995; 92(4): 796 - 804. [Abstract] [Full Text]